Document is current
Any future updates will be listed below
-
Authors
Davis, Stacy
Skalicky, Anne
Beaudet, Amélie
Bayer, Bjorn
Kleinman, Leah
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals, Inc.
- License Information
-
More Information
Article History
Received: 17 May 2024
Accepted: 22 April 2025
First Online: 6 May 2025
Declarations
:
: This study was performed in accordance with the provisions of the Declaration of Helsinki, International Conference on Harmonization Guideline for Good Clinical Practice, Good Pharmacoepidemiology Practice, and the applicable legislation on Non-Interventional Studies and/or Observational Studies. The study protocol and consent forms were approved by the Western-Copernicus Group institutional review board (no. 20225418). Informed consent was obtained from all subjects and/or their legal guardian(s).
: Not applicable.
: AS and LK are employees of Evidera and received payment from Janssen Pharmaceuticals, Inc. for conducting the study. SD is an employee of Janssen Pharmaceuticals, Inc. AB and BB are employees of Actelion Pharmaceuticals Ltd., a Janssen Pharmaceutical Company of Johnson & Johnson.
